Gonadal steroids as predictors of sex differences in tuberculosis outcomes
JCI Insight · 10.08.2026 · 11 (15)
DOI: 10.1172/jci.insight.200877 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, online erschienen am 16.06.2026. Verfasst von Djeneba Dabitao und 25 weiteren Autor:innen. Beteiligte Einrichtung: University Clinical Research Center, Faculty of Pharmacy and Faculty of Medicine and Odonto-Stomatology, University of Sciences, Techniques, and Tech…. Hauptthemen laut MEDLINE: Testosterone, Estradiol, Tuberculosis, Pulmonary, Gonadal Steroid Hormones. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FIC NIH HHS, NIAID NIH HHS, Fogarty International Center (FIC) and the Office of the Director (OD) of the US National Institutes of Health.
Abstract (Originalsprache)
BACKGROUND Recent evidence suggests a role for biological factors in increased risk for active pulmonary tuberculosis (PTB) among males. We determined the relationship between alterations in gonadal steroids, tuberculosis (TB) disease status, and treatment outcomes. METHODS We conducted a prospective cohort study in Mali of treatment naïve males and females with laboratory-confirmed PTB, latent TB infection (LTBI), and healthy controls of similar ages. RESULTS Prior to treatment, males with PTB had lower testosterone concentrations compared to males with LTBI or healthy males. Reduced testosterone concentrations in males with PTB were transient, returning to healthy ranges by month 2 of treatment, which corresponded to the end of intensive TB treatment. Estradiol concentrations in females were not altered by PTB or infection status yet increased at month 6 of treatment. Testosterone, but not estradiol, was a strong predictor of cure during treatment. Testosterone, but not estradiol, concentrations in PTB cases were inversely correlated with serum IFN-γ, IL-6, and IL-2. Concentrations of IL-17 and IL-10 were lower in males than females at the end of TB treatment. CONCLUSION Our results suggest that TB-induced changes in testosterone concentrations during PTB and in response to treatment occur in males and could contribute to sex differences in TB pathogenesis. FUNDING The Fogarty International Center and the Office of Research on Women’s Health (K43TW011426); the Institute for Global Health at the Feinberg School of Medicine of the Northwestern University (Catalyzer Award); 2021 TWAS Abdool Karim Award; NIH grants R37AI167750 and 5D43TW010350.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University Clinical Research Center, Faculty of Pharmacy and Faculty of Medicine and Odonto-Stomatology, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
- Department of Pneumophtisiology, Teaching Hospital of Point-G, Bamako, Mali.
- Division of Infectious Diseases and Havey Institute for Global Health, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
- Biological Sciences Division, University of Chicago, Chicago, Illinois, USA.
- Department of Infectious Diseases, Center for Tuberculosis Research, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
- W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Förderung
- FIC NIH HHS
- NIAID NIH HHS
- Fogarty International Center (FIC) and the Office of the Director (OD) of the US National Institutes of Health
- Institute for Global Health (IGH) at the Feinberg School of Medicine of the Northwestern University
- The World Academy of Sciences (TWAS)/UNESCO
- US National Institutes of Health
- Fogarty International Center (FIC) of the US National Institutes of Health
Zitieren
APA
Dabitao, D., Baya, B., Sanogo, I., Somboro, A., Wague, M., Coulibaly, M. D., Koloma, I., Kone, M., Nantoume, M., Coulibaly, N., Behinan, S., Coulibaly, M., Perou, M., Sanogo, M., Diarra, A., Samake, S., Diarra, B., Diakite, M., Diallo, S., …, & Klein, S. (2026). Gonadal steroids as predictors of sex differences in tuberculosis outcomes. JCI Insight, 11(15). https://doi.org/10.1172/jci.insight.200877
Vancouver
Dabitao D, Baya B, Sanogo I, Somboro A, Wague M, Coulibaly MD, et al. Gonadal steroids as predictors of sex differences in tuberculosis outcomes. JCI Insight. 2026;11(15). doi:10.1172/jci.insight.200877
BibTeX
@article{Dabitao2026,
author = {Dabitao, Djeneba and Baya, Bocar and Sanogo, Ibrahim and Somboro, Amadou and Wague, Mamadou and Coulibaly, Mamadou D and Koloma, Isaac and Kone, Mahamadou and Nantoume, Mohamed and Coulibaly, Nadie and Behinan, Stephane and Coulibaly, Mariam and Perou, Mamadou and Sanogo, Moumine and Diarra, Ayouba and Samake, Seydou and Diarra, Bassirou and Diakite, Mahamadou and Diallo, Souleymane and Toloba, Yacouba and Achenbach, Chad and Holl, Jane L and Doumbia, Seydou and Murphy, Robert and Bishai, William and Klein, Sabra},
title = {Gonadal steroids as predictors of sex differences in tuberculosis outcomes},
journal = {JCI Insight},
year = {2026},
volume = {11},
number = {15},
doi = {10.1172/jci.insight.200877}
}
EUVIMED